Cyclacel Pharmaceuticals to Present at BIO Investor Forum
October 21, 2009 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Oct. 21, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer Spiro Rombotis will...
Cyclacel to Present At Annual Rodman & Renshaw Healthcare Conference
September 03, 2009 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced that Spiro Rombotis, President and CEO,...
Cyclacel Pharmaceuticals Announces Receipt of NASDAQ Notice
August 28, 2009 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 28, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), ("Cyclacel" or the "Company"), announced that it received a letter on August 24,...
Cyclacel Pharmaceuticals Announces Second Quarter 2009 Financial Results
August 06, 2009 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today financial and operating results for...
Cyclacel Pharmaceuticals to Announce Second Quarter 2009 Financial Results On August 6, 2009
July 31, 2009 16:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., July 31, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") will announce second quarter 2009 financial results...
Cyclacel Completes Previously Announced Registered Direct Offering
July 30, 2009 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., July 30, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that it completed its previously...
Cyclacel to Raise Up to $5.9 Million in Registered Direct Offering
July 24, 2009 08:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., July 24, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that it has entered into definitive...
Cyclacel to Present At Annual Needham Biotechnology and Medical Technology Conference
June 09, 2009 09:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 9, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced that Spiro Rombotis, President and CEO, will present an overview of the...
Sapacitabine Has Anti-Cancer Activity in Combination With Targeted Agents and Other Nucleoside Analogs
June 08, 2009 10:19 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 8, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced that Cyclacel scientists reported preclinical data supporting potential...
Cyclacel Reports Initial Phase 2 Seliciclib Data in Patients With Nasopharyngeal Carcinoma At 2009 ASCO Annual Meeting
May 29, 2009 15:00 ET
|
Cyclacel
ORLANDO, Fla., May 29, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) today announced interim data from the lead-in stage of a Phase 2 randomized clinical trial...